BlackRock's position in Cardinal Health is currently worth $5.75B. That's 0.09% of their equity portfolio (188th largest holding). The investor owns 12.47% of the outstanding Cardinal Health stock. The first Cardinal Health trade was made in Q4 2020. Since then BlackRock bought shares seven more times and sold shares on ten occasions. The stake costed the investor $1.85B, netting the investor a gain of 211% so far.
Cardinal Health (CAH) closed at $95.97 in the latest trading session, marking a +0.59% move from the prior day.
Cardinal Health (CAH) concluded the recent trading session at $93.74, signifying a -0.38% move from its prior day's close.
Cardinal Health (CAH) gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.
Dividend stocks have long been investor favorites. Not only do dividends provide a reliable stream of income but they also increase a portfolio's returns ove...